Sometimes the biggest plans can overlook the smallest details. Could this be a piece of fortunate serendipity? An unexpected pushback from our old friends in the insurance industry?
It’s not looking good, partaking in a giant experiment and expecting to be ID prioritised and free to roam the planet at will has its issues. Not only this, how are the airlines going to be able to afford the risk assessment value for taking-off with a cabin full of GMP’s? Surely, with all the risk of seizures and diverse reactions to the experimental jabs that we’re seeing, it would cost them millions in premiums to be able to leave the tarmac.
Get ready for some revelations.